Key Details
Price
$2.53Annual Revenue
$1.34 MAnnual EPS
$0.14Annual ROE
3.52%Beta
0.85Events Calendar
Next earnings date:
May 09, 2025Recent quarterly earnings:
Nov 07, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Jan 23, 2013Analyst ratings
Recent major analysts updates
09 Sept '24 HC Wainwright & Co.
Neutral20 May '24 HC Wainwright & Co.
Neutral17 May '23 Canaccord Genuity
Hold17 Jan '23 HC Wainwright & Co.
Neutral12 Jan '23 Canaccord Genuity
Hold16 May '22 Aegis Capital
Buy18 Feb '22 Cantor Fitzgerald
Overweight30 Nov '21 HC Wainwright & Co.
Buy29 Nov '21 HC Wainwright & Co.
Buy02 Nov '21 Aegis Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Oramed Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
FAQ
- What is the primary business of Oramed Pharmaceuticals?
- What is the ticker symbol for Oramed Pharmaceuticals?
- Does Oramed Pharmaceuticals pay dividends?
- What sector is Oramed Pharmaceuticals in?
- What industry is Oramed Pharmaceuticals in?
- What country is Oramed Pharmaceuticals based in?
- When did Oramed Pharmaceuticals go public?
- Is Oramed Pharmaceuticals in the S&P 500?
- Is Oramed Pharmaceuticals in the NASDAQ 100?
- Is Oramed Pharmaceuticals in the Dow Jones?
- When was Oramed Pharmaceuticals's last earnings report?
- When does Oramed Pharmaceuticals report earnings?
- Should I buy Oramed Pharmaceuticals stock now?
What is the primary business of Oramed Pharmaceuticals?
Oramed Pharmaceuticals is a biotechnology company focused on developing oral drug delivery systems, particularly for diabetes treatment. Their innovative approach aims to provide patients with easier and more convenient ways to manage their health, improving adherence to medication and overall quality of life.
What is the ticker symbol for Oramed Pharmaceuticals?
The ticker symbol for Oramed Pharmaceuticals is NASDAQ:ORMP
Does Oramed Pharmaceuticals pay dividends?
No, Oramed Pharmaceuticals does not pay dividends
What sector is Oramed Pharmaceuticals in?
Oramed Pharmaceuticals is in the Healthcare sector
What industry is Oramed Pharmaceuticals in?
Oramed Pharmaceuticals is in the Biotechnology industry
What country is Oramed Pharmaceuticals based in?
Oramed Pharmaceuticals is headquartered in United States
When did Oramed Pharmaceuticals go public?
Oramed Pharmaceuticals's initial public offering (IPO) was on 01 May 2007
Is Oramed Pharmaceuticals in the S&P 500?
No, Oramed Pharmaceuticals is not included in the S&P 500 index
Is Oramed Pharmaceuticals in the NASDAQ 100?
No, Oramed Pharmaceuticals is not included in the NASDAQ 100 index
Is Oramed Pharmaceuticals in the Dow Jones?
No, Oramed Pharmaceuticals is not included in the Dow Jones index
When was Oramed Pharmaceuticals's last earnings report?
Oramed Pharmaceuticals's most recent earnings report was on 7 November 2024
When does Oramed Pharmaceuticals report earnings?
The next expected earnings date for Oramed Pharmaceuticals is 9 May 2025
Should I buy Oramed Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions